MORN trades 6.9% above Wall Street's consensus target of $227.33.
Last 12 months price action with 12-month analyst target path
The base valuation assumes MORN achieves its forward estimates and maintains a stable P/E multiple of 18.6x. This scenario reflects the blended consensus of 6 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 9, 2026, Morningstar, Inc. (MORN) has a Wall Street consensus price target of $227.33, based on estimates from 6 covering analysts. With the stock currently trading at $244.15, this represents a potential downside of -6.9%. The company has a market capitalization of $9.16B.
Analyst price targets range from a low of $210.00 to a high of $260.00, representing a 22% spread in expectations. The median target of $212.00 differs from the mean, suggesting potential outlier estimates. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 2 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 0 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, MORN trades at a trailing P/E of 27.5x and forward P/E of 18.6x. The forward PEG ratio of 1.64 indicates reasonable valuation for growth. Analysts expect EPS to grow +11.3% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $402.87, with bear and bull scenarios of $253.81 and $530.82 respectively. Model confidence stands at 55/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 MSCIMSCI Inc. | $46.6B | $641.01 | $687.70 | +7.3% | Buy | 32.5x | 27 |
 SPGIS&P Global Inc. | $137.9B | $467.80 | $512.14 | +9.5% | Buy | 26.1x | 28 |
 MCOMoody's Corporation | $87.6B | $505.67 | $536.44 | +6.1% | Buy | 30.1x | 32 |
 FDSFactSet Research Systems Inc. | $11.7B | $327.89 | $260.08 | -20.7% | Hold | 16.7x | 30 |
 ICEIntercontinental Exchange, Inc. | $97.2B | $172.27 | $183.89 | +6.7% | Buy | 21.0x | 36 |
 LSELeishen Energy Holding Co., Ltd. | $76M | $4.48 | — | — | — | — | — |
 VRSKVerisk Analytics, Inc. | $26.6B | $204.59 | $222.86 | +8.9% | Hold | 26.5x | 25 |
 TRIThomson Reuters Corporation | $49.1B | $112.57 | $118.00 | +4.8% | Buy | 27.5x | 27 |
 BLKBlackRock, Inc. | $182.7B | $1178.87 | $1341.45 | +13.8% | Buy | 20.4x | 33 |
 TROWT. Rowe Price Group, Inc. | $23.2B | $108.41 | $110.83 | +2.2% | Hold | 10.6x | 38 |
Quick answers to the most common questions about buying MORN stock.
Wall Street's consensus price target for MORN is $227.33, -6.9% from its current price of $244.15. The below-market target from 6 analysts suggests limited near-term appreciation.
MORN has a consensus rating of "Hold" based on 6 Wall Street analysts. The rating breakdown is mixed, with 4 Hold ratings making up the largest segment. The consensus 12-month price target of $227.33 implies -6.9% downside from current levels.
With a forward P/E of 18.6081x, MORN trades at a relatively low valuation. The consensus target of $227.33 implies -6.9% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $260 for MORN, while the most conservative target is $210. The consensus of $227.33 represents the median expectation. Our quantitative valuation model projects a bull case target of $531 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
MORN is moderately covered, with 6 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 4 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month MORN stock forecast based on 6 Wall Street analysts shows a consensus price target of $227.33, with estimates ranging from $210 (bear case) to $260 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $403, with bear/bull scenarios of $254/$531.
Our quantitative valuation model calculates MORN's fair value at $403 (base case), with a bear case of $254 and bull case of $531. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 55/100.
MORN trades at a forward P/E ratio of 18.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 27.5x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on MORN, with 0 Sell ratings and a price target of $227.33 (-6.9% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
MORN analyst price targets range from $210 to $260, a 22% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $227.33 consensus represents the middle ground. Our model's $254-$531 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.